verified99%+ Verified Purity
local_shippingFast EU Delivery (through resellers)
Homechevron_rightAll Peptideschevron_rightSNAP-8
SNAP-8
verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-snap-8-10mg

Official Product Data Sheet

SNAP-8 (10mg)

Research Grade >99.2% Purity

Vial Contents
10 mg SNAP-8 (lyophilized powder)
Includes
3 ml bacteriostatic water for reconstitution
Form
Freeze-dried white powder
Purity
≥99%, third-party confirmed (COA available)
Sequence
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂
Molecular Formula
C41H70N16O16S
Molecular Mass
1075.2 g/mol
CAS No.
868844-74-0
Solubility
Reconstitutes readily in bacteriostatic water to ~3.33 mg/mL
Storage
Lyophilized frozen at −20 °C; reconstituted refrigerated at 2–8 °C for up to 4 weeks

Authorized Resellers

Available through our trusted partners

12
verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new
DE
verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new
View all authorized resellersshopping_cart
swipe_rightSwipe to see all tabs

Scientific Background

SNAP-8 is a synthetic octapeptide designed as an extended and enhanced analog of the hexapeptide Argireline (Acetyl Hexapeptide-3). It replicates the N-terminal sequence of the synaptosomal-associated protein SNAP-25 — a critical component of the SNARE complex responsible for vesicular neurotransmitter release at neuromuscular junctions.

By competing with SNAP-25 for incorporation into the SNARE complex, SNAP-8 reduces the assembly efficiency of the synaptic fusion machinery, thereby decreasing acetylcholine release at neuromuscular junctions. This results in a partial, reversible reduction in muscle contractility — analogous to the mechanism of botulinum toxin (Botox), but acting at the SNARE protein level rather than through proteolytic cleavage. The effect is therefore significantly milder and fully reversible, producing muscle relaxation without immobilisation.

Research comparing SNAP-8 to Argireline demonstrates approximately 30% greater efficacy in reducing neurotransmitter release. In aesthetic and dermatological research contexts, SNAP-8 is investigated for its ability to reduce the appearance of dynamic expression lines (particularly forehead and periorbital wrinkles) through sustained, localised muscle tone modulation. Studies report average wrinkle depth reduction of ~35%, with peak reductions approaching 60% in targeted areas after 28-day application protocols.

Intended Research Use

  • SNARE complex modulation and neuromuscular junction research
  • Dynamic wrinkle reduction via partial muscle relaxation models
  • Comparative SNARE-targeting peptide pharmacology (SNAP-8 vs. Argireline)
  • Topical and subcutaneous delivery mechanism studies for cosmeceutical peptides
  • Neurotransmitter release inhibition without proteolytic cleavage
  • Acetylcholine release modulation at peripheral neuromuscular junctions
warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Myotrope

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

SNAP-8 is commonly combined with complementary skin and collagen-focused peptides for comprehensive dermal regeneration and aesthetic research protocols.

schedule

Cycling Note: Standard protocols: 8–12 weeks with consistent daily dosing. Results typically require continuous administration to maintain — discontinuation allows gradual return to baseline muscle tone.